These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 32490978)
21. Macular pseudohole development after sustained-release dexamethasone intravitreal implant for macular edema due to central retinal vein occlusion. Di Antonio L; Toto L; Carpineto P; Mastropasqua A; De Nicola C; Mastropasqua L Eur J Ophthalmol; 2014; 24(1):134-7. PubMed ID: 23709332 [TBL] [Abstract][Full Text] [Related]
22. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients. Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J Retina; 2013; 33(7):1435-40. PubMed ID: 23514796 [TBL] [Abstract][Full Text] [Related]
23. Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling. Bonfiglio V; Fallico MR; Russo A; De Grande V; Longo A; Uva MG; Reibaldi M; Avitabile T Eur J Ophthalmol; 2015 Jul; 25(5):e98-e100. PubMed ID: 25790811 [TBL] [Abstract][Full Text] [Related]
24. Objective evaluation of lens clarity after the intravitreal injection of sustained-release dexamethasone implant. Anayol MA; Sekeroglu MA; Tirhis H; Gulpamuk B; Doguizi S; Yilmazbas P J Cataract Refract Surg; 2016 Oct; 42(10):1477-1482. PubMed ID: 27839603 [TBL] [Abstract][Full Text] [Related]
25. Intralenticular Sustained-Release Dexamethasone Implant: Is It Still Effective on Macular Edema? Sekeroglu MA; Anayol MA; Koc F; Tirhis H; Ozkan SS; Yilmazbas P Case Rep Ophthalmol; 2016; 7(1):85-9. PubMed ID: 27293406 [TBL] [Abstract][Full Text] [Related]
26. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion. Moon SY; Cho KH; Woo SJ; Park SP; Kim YK Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223 [TBL] [Abstract][Full Text] [Related]
27. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema. Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U; Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922 [TBL] [Abstract][Full Text] [Related]
28. Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant. Stelton CR; Townsend J; Peterson LT; Khurana RN; Yeh S Ophthalmic Surg Lasers Imaging Retina; 2015; 46(7):756-9. PubMed ID: 26247457 [TBL] [Abstract][Full Text] [Related]
29. Dexamethasone Intravitreal Implant in the Treatment of Uveitic Macular Edema in the Perioperative Cataract Setting: A Case Series. Larochelle MB; Smith J; Dacey MS Am J Ophthalmol; 2016 Jun; 166():149-153. PubMed ID: 27066725 [TBL] [Abstract][Full Text] [Related]
30. PROSPECTIVE EVALUATION OF A SUSTAINED-RELEASE DEXAMETHASONE INTRAVITREAL IMPLANT FOR CYSTOID MACULAR EDEMA IN QUIESCENT UVEITIS. Khurana RN; Bansal AS; Chang LK; Palmer JD; Wu C; Wieland MR Retina; 2017 Sep; 37(9):1692-1699. PubMed ID: 27893624 [TBL] [Abstract][Full Text] [Related]
31. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema. Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of Multiple Dexamethasone Intravitreal Implants for Refractory Retinal Vein Occlusion-Related Macular Edema and Effect of Prior Vitrectomy. Houben I; De Zaeytijd J; Deghislage C; Frost NA; Nijs I; Van Calster J J Ocul Pharmacol Ther; 2018 Dec; 34(10):710-719. PubMed ID: 30403557 [No Abstract] [Full Text] [Related]
33. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series. Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790 [TBL] [Abstract][Full Text] [Related]
34. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study. Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA; BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664 [TBL] [Abstract][Full Text] [Related]
37. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®). Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910 [TBL] [Abstract][Full Text] [Related]
38. Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion. Abdolrahimzadeh S; Plateroti P; Scarinci F; Plateroti AM Acta Ophthalmol; 2016 Dec; 94(8):e810-e811. PubMed ID: 27125991 [No Abstract] [Full Text] [Related]
39. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis. Kim M; Kim SA; Park W; Kim RY; Park YH Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122 [TBL] [Abstract][Full Text] [Related]
40. Widening use of dexamethasone implant for the treatment of macular edema. Bonfiglio V; Reibaldi M; Fallico M; Russo A; Pizzo A; Fichera S; Rapisarda C; Macchi I; Avitabile T; Longo A Drug Des Devel Ther; 2017; 11():2359-2372. PubMed ID: 28860707 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]